MX2023005320A - Materiales y metodos para el procesamiento de proteinas. - Google Patents

Materiales y metodos para el procesamiento de proteinas.

Info

Publication number
MX2023005320A
MX2023005320A MX2023005320A MX2023005320A MX2023005320A MX 2023005320 A MX2023005320 A MX 2023005320A MX 2023005320 A MX2023005320 A MX 2023005320A MX 2023005320 A MX2023005320 A MX 2023005320A MX 2023005320 A MX2023005320 A MX 2023005320A
Authority
MX
Mexico
Prior art keywords
materials
methods
protein processing
protein
processing
Prior art date
Application number
MX2023005320A
Other languages
English (en)
Inventor
Sreekanth Suravajjala
Jennifer Lynn Lippens
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX2023005320A publication Critical patent/MX2023005320A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

En el presente documento se describen materiales y métodos para la producción y el análisis de proteínas.
MX2023005320A 2020-11-05 2021-11-01 Materiales y metodos para el procesamiento de proteinas. MX2023005320A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063110087P 2020-11-05 2020-11-05
PCT/US2021/057519 WO2022098595A1 (en) 2020-11-05 2021-11-01 Materials and methods for protein processing

Publications (1)

Publication Number Publication Date
MX2023005320A true MX2023005320A (es) 2023-05-19

Family

ID=79021031

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023005320A MX2023005320A (es) 2020-11-05 2021-11-01 Materiales y metodos para el procesamiento de proteinas.

Country Status (7)

Country Link
US (1) US20240010672A1 (es)
EP (1) EP4240747A1 (es)
JP (1) JP2023549113A (es)
AU (1) AU2021376246A1 (es)
CA (1) CA3200262A1 (es)
MX (1) MX2023005320A (es)
WO (1) WO2022098595A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12110324B2 (en) 2022-07-22 2024-10-08 Flagship Pioneering Innovations Vi, Llc Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0212136A (pt) 2001-08-23 2004-12-07 Genmab As Anticorpo monoclonal humano isolado, métodos para inibir a produção de tnfa em células t ou monócitos e a proliferação de célula t, hibridoma, transfectoma, animal não humano transgênico, método para produzir um anticorpo monoclonal humano, composição farmacêutica, métodos para tratar ou prevenir um distúrbio mediado pela il-15 humana, a psorìase e a artrite reumatóide, método para diagnosticar uma doença, ácido nucleico, e, vetor de expressão
US7592429B2 (en) 2005-05-03 2009-09-22 Ucb Sa Sclerostin-binding antibody
US8003108B2 (en) 2005-05-03 2011-08-23 Amgen Inc. Sclerostin epitopes
BRPI0813725A2 (pt) 2007-06-20 2014-12-30 Irm Llc Métodos e composições para tratamento de doenças
US7982016B2 (en) 2007-09-10 2011-07-19 Amgen Inc. Antigen binding proteins capable of binding thymic stromal lymphopoietin
TWI516501B (zh) 2008-09-12 2016-01-11 禮納特神經系統科學公司 Ｐｃｓｋ９拮抗劑類
US11761932B2 (en) * 2019-06-07 2023-09-19 Waters Technologies Corporation RPLC-based peptide mapping chromatographic performance using metal chelators as mobile phase additives

Also Published As

Publication number Publication date
JP2023549113A (ja) 2023-11-22
WO2022098595A1 (en) 2022-05-12
AU2021376246A9 (en) 2024-10-03
CA3200262A1 (en) 2022-05-12
AU2021376246A1 (en) 2023-06-08
US20240010672A1 (en) 2024-01-11
EP4240747A1 (en) 2023-09-13

Similar Documents

Publication Publication Date Title
WO2020123316A3 (en) Methods for determining a location of a biological analyte in a biological sample
AU2017259794A1 (en) Macromolecule analysis employing nucleic acid encoding
MX2020008542A (es) Composiciones y métodos para el suministro de proteínas membranales.
EP3836967A4 (en) METHODS AND SYSTEMS FOR SAMPLE PROCESSING OR ANALYSIS
MX2021005353A (es) Composiciones, metodos y sistemas para el analisis de la corona proteica y usos de los mismos.
DK202300015Y9 (da) Ikke-animalsk baserede proteinkilder med funktionelle egenskaber
EP3848936A4 (en) PROCEDURES FOR IDENTIFICATION AND CLASSIFICATION OF SAMPLE MICROORGANISMS
DK202300014Y9 (da) Proteinsammensætninger og konsumerbare produkter deraf
IL287318A (en) Materials and methods for the production of proteins
MX2023009893A (es) Materiales basados en micelio que incluyen aislamiento de alto rendimiento y métodos relacionados.
MX2018012550A (es) Composiciones y metodos para la deteccion de proteinas de celulas huesped.
MX2021004649A (es) Método y sistema para la identificacion y cuantificacion de una proteína.
MX2022012296A (es) Proceso mediado por enzimas para la elaboracion de amberketal y homologos de amberketal.
PH12017500047A1 (en) Dual cistronic bacterial expression system
MX2020011529A (es) Un metodo para optimizar la expresion de anticuerpos.
MX2017005925A (es) Metodos de producción de proteínas de cadena doble en bacterias.
DK3735478T3 (da) Mutante og genmodificerede bacillus-celler og fremgangsmåder dertil til forøget proteinproduktion
ZA202102546B (en) Methods for identifying free thiols in proteins
MX2020009231A (es) Materiales biofabricados con forma tridimensional y metodos de fabricacion.
SG10201913513TA (en) Method of providing biological data, method of encrypting biological data, and method of processing biological data
WO2023009529A3 (en) Novel polypeptides and uses thereof
EP4153608A4 (en) METHODS, SYSTEMS AND KITS FOR THE PROCESSING AND ANALYSIS OF POLYPEPTIDES
MX2023005320A (es) Materiales y metodos para el procesamiento de proteinas.
EP3848806A4 (en) INFORMATION PROCESSING DEVICE, LOG ANALYSIS PROCESS, AND PROGRAM
EA202091916A1 (ru) Способ и устройство расщепления бобовых